(S)-4-Methyl-2-(methylamino)pentanoic acid hydrochloride, 95.0%, 100g

3-[2-(2-Aminoethoxy)ethoxy]propanoic acid 1,1-dimethylethyl ester, 95.0%, 5g

6-Bromo-benzo[1,3]dioxole-5-carbaldehyde, 98.0%, 10g

Potassium ethyl xanthate, 80.0%, 5g

N,N'-Diphenyl-N,N'-di(p-tolyl)benzidine>98.0%(GC)200mg

4,4'-Dihydroxyazobenzene>98.0%(HPLC)(T)1g

2-CHLORO-3,4-DIFLUOROBENZYL BROMIDE, 95.0%, 1g

3-Amino-1-(3,4-dimethylphenyl)thiourea, 95+%, 250mg

PMPip BTA, 100 g, >=99 %, envase de vidrio

CEFAZEDONE, 95%, 25g

3,4-Diphenyl-pyrrole, 98.0%, 1g

Fmoc-(S)-3-Amino-3-(3-trifluoromethyl-phenyl)-propionic acid, 97%, 100mg

Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate, 95.0%, 5g